NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Diatiro Health

Diatiro Health

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.diatirohealth.com/

Last Round

Seed

Jul 15, 2024

Total Funding Raised

$30,000

Company Overview

Diatiro Health is a medical technology company that designs innovative organ preservation devices to improve surgical outcomes in kidney transplantation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

organ preservationmedical devicekidney transplantorgan perfusiondelayed graft functiontransplant technologymedtechFDA breakthrough deviceorgan transporttransplant surgerycold storagetransplant hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Diatiro Health Comps

Public and private peers based on sector, stage, and business model.

Diatiro Health comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Diatiro Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 15, 2024
GrantMay 10, 2024
VC RoundSep 21, 2023

Key People

Founding team and executive leadership

Keith Hansen

Founder & CEO

Founding Team

Diatiro Health Investors

Notable investors and investment history

Diatiro Health investors
InvestorRounds
Engage Venture PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 10, 2024

    $30K grant received from Society of American Gastrointestinal and Endoscopic Surgeons.

Diatiro Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Diatiro Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Diatiro Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range7
Year FoundedN/A
Last FundingJul 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.